| （単位：千ドル） | 3Q19 | 1Q20 | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 4,910 | 9,096 | 10,694 | 8,761 | 6,763 | 6,654 | 6,015 | 4,089 | - | - | - | - | - | - | - | - | - |
| 営業費用 | 7,218 | 11,872 | 14,480 | 12,234 | 10,189 | 9,997 | 9,430 | 8,074 | 98,465 | 4,200 | 4,622 | 3,901 | 3,842 | 3,530 | 4,408 | 4,451 | 4,248 |
| 営業利益 | - | - | - | - | - | - | - | - | - | - | - | -3,652 | -3,523 | -3,150 | -3,847 | -4,098 | -4,086 |
| 純利益 | -6,250 | -9,401 | -16,368 | -12,319 | -9,669 | -10,252 | -9,453 | -7,937 | -98,259 | -4,025 | -4,380 | -3,260 | -3,205 | -2,811 | -3,471 | -3,784 | -3,933 |
| 一株あたり利益 | - | - | - | - | - | - | -0.45 | -0.36 | -4.34 | -0.12 | -1.34 | -0.87 | -0.86 | -0.67 | -0.58 | -0.64 | -0.66 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.45 | -0.36 | -4.34 | -0.12 | -1.34 | -0.87 | -0.85 | -0.67 | -0.58 | -0.64 | -0.66 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |